Abemaciclib metabolite M18-d8

• CAT Number: S000912
• Molecular Formula: C25H20D8F2N8O
• Molecular Weight: 502.59
• Purity: ≥95%
• Target: PROTAC
• IUPAC Name: [4-fluoro-6-[5-fluoro-2-[[5-[(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)methyl]pyridin-2-yl]amino]pyrimidin-4-yl]-1-propan-2-ylbenzimidazol-2-yl]methanol
• InChI: InChI=1S/C25H28F2N8O/c1-15(2)35-20-10-17(9-18(26)24(20)32-22(35)14-36)23-19(27)12-30-25(33-23)31-21-4-3-16(11-29-21)13-34-7-5-28-6-8-34/h3-4,9-12,15,28,36H,5-8,13-14H2,1-2H3,(H,29,30,31,33)/i5D2,6D2,7D2,8D2
• InChIKey: YQMRQLBCUBZXEP-YEBVBAJPSA-N
• SMILES: [2H]C1(C(N(C(C(N1)([2H])[2H])([2H])[2H])CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)CO)F)([2H])[2H])[2H]

Abemaciclib Metabolite M18-d8 is a high-purity deuterated compound essential for advanced pharmaceutical and biochemical research. This isotopically labeled version of Abemaciclib Metabolite M18, featuring eight deuterium atoms, is crucial for studies involving cancer drug metabolism, pharmacokinetics, and drug interaction analysis. Its stable isotope labeling ensures precise and reliable analytical results. With enhanced stability and consistency, it is suitable for various experimental setups. Ideal for oncology research and drug development, Abemaciclib Metabolite M18-d8 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.